255
Participants
Start Date
April 30, 2019
Primary Completion Date
February 4, 2020
Study Completion Date
February 4, 2020
BPN14770
Drug BPN14770
Placebo
Placebo
Manhattan Behavioral Medicine PLLC, New York
Neurological Associates of Long Island, Lake Success
Integrative Clinical Trials, Brooklyn
Lehigh Center for Clinical Research, Allentown
Alzheimers Memory Center, Charlotte
Neurology Associates of Ormond Beach, Ormond Beach
Synergy Clinical Research, Pensacola
Gutierrez Medical Center LLD, Orlando
MD Clinical, Hallandale
Galiz Research, Hialeah
Quantum Laboratories, Pompano Beach
Optimus Clinical Research, Miami
BioMed Research Institute, Miami
Finlay Medical Research, Miami
Pharmax Research Clinic, Miami
Linfritz Research Group, Coral Gables
Vitae Research Center, LLC, Miami
Arocha Research Center, Miami
Allied Biomedical Research Institute Inc., Miami
IMIC Inc, Palmetto Bay
Advanced Clinical Research Network, Miami
Palm Beach Neurological Center, Palm Beach
Brain Matters Research, Delray Beach
Alzheimer's Research and Treatement Center, Lake Worth
JEM Research Insitute, Atlantis
Neurology Clinic, P.C., Cordova
MDH Research, Westerville
Neurology Diagnostics, Inc., Dayton
Neurosciences Research, Elk Grove Village
Mile High Research Center, Denver
Aspen Clinical Research, Orem
Wasatch Clinical Research, LLC, Salt Lake City
Generations at Agritopia/CCT Research, Gilbert
CiTrials, Inc., Bellflower
Alliance for Research, Long Beach
Pacific Research Network Inc., San Diego
ATP Clinical Research, Inc, Costa Mesa
HB Clinical Trials, Inc., Santa Ana
Summit Research Network, Portland
Hassman Research Institute, Berlin
Advanced Memory Research Institute of NJ PC, Toms River
Lead Sponsor
Tetra Discovery Partners
INDUSTRY